• Fda Approval Received for Her2 Image Analysis Application

Laboratory Products

Fda Approval Received for Her2 Image Analysis Application

Apr 24 2008

Aperio Technologies, Inc has received clearance from the US Food and Drug Administration (FDA) to market the HER2 image analysis application available through its patented ScanScope® slide scanning system. The FDA-cleared immunohistochemistry (IHC) image analysis application is
intended to be used as an aid to pathologists in detecting and quantifying HER2 protein expression from digital slide images created by Aperio’s slide scanning systems.
Aperio’s FDA clearance encompasses the company’s complete digital pathology system, including ScanScope® scanners for creating digital slide images from microscope slides, the Spectrum™ digital pathology information management system for managing, viewing, and analysing
digital slides, and the specific image analysis application which performs the automated scoring of IHC HER2 breast cancer digital slides.

Digital Edition

Lab Asia 30.2 - April 2023

April 2023

In This Edition Chromatography Articles - On-Column Sample Focussing: a Personal Perspective Mass Spectrometry & Spectroscopy Articles - Multi-scale, multi-modal and operando imaging wi...

View all digital editions

Events

MSACL 2023

Apr 02 2023 Monterey, CA, USA

Analitika Expo 2023

Apr 11 2023 Moscow, Russia

Microbiology Society Annual Conference 2023

Apr 17 2023 Birmingham, UK

Korea Lab 2023

Apr 18 2023 Kintex, South Korea

Analytica Vietnam

Apr 19 2023 Ho Chi Minh City, Vietnam

View all events